Daraxonrasib reduced mortality risk versus chemotherapy in previously treated RAS G12–mutant mPDAC (OS HR 0.40) with fewer discontinuations and delayed pain/QoL deterioration. Perioperative ...
Scientists may have found a completely new way to treat depression by targeting inflammation instead of brain chemistry.
The Illinois spring legislative session ended early Monday morning after state lawmakers went into overtime, hours past the ...
Chronic inflammation occurs when the body's immune system stays active even in the absence of any threat. Dr Sood shares ...
Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results